Management attributed overperformance in 2025 to strong execution across all segments and a successful first year of the 2025-2027 long-range plan.Strategic positioning was strengthened by securing a 25-year license renewal for the Ottawa facility, the longest ever issued by the Canadian Nuclear Safety Commission.Cross-business unit (XBU) initiatives gained momentum, with revenue from customers using multiple segments growing 9% year-over-year.Nelson Labs achieved significant margin expansion of 312 basis p ...